Literature DB >> 27798223

Ventral Striatal Dysfunction and Symptom Expression in Individuals With Schizotypal Personality Traits and Early Psychosis.

Matthias Kirschner1, Oliver M Hager1,2, Larissa Muff1, Martin Bischof1, Matthias N Hartmann-Riemer1,2, Agne Kluge1, Benedikt Habermeyer1, Erich Seifritz1, Philippe N Tobler2, Stefan Kaiser1.   

Abstract

Striatal abnormalities play a crucial role in the pathophysiology of schizophrenia. Growing evidence suggests an association between aberrant striatal activity during reward anticipation and symptom dimensions in schizophrenia. However, it is not clear whether this holds across the psychosis continuum. The aim of the present study was to investigate alterations of ventral striatal activation during reward anticipation and its relationship to symptom expression in persons with schizotypal personality traits (SPT) and first-episode psychosis. Twenty-six individuals with high SPT, 26 patients with non-affective first-episode psychosis (including 13 with brief psychotic disorder (FEP-BPD) and 13 with first-episode schizophrenia [FEP-SZ]) and 25 healthy controls underwent event-related functional magnetic resonance imaging while performing a variant of the Monetary Incentive Delay task. Ventral striatal activation was positively correlated with total symptom severity, in particular with levels of positive symptoms. This association was observed across the psychosis continuum and within each subgroup. Patients with FEP-SZ showed the strongest elevation of striatal activation during reward anticipation, although symptom levels did not differ between groups in the psychosis continuum. While our results provide evidence that variance in striatal activation is mainly explained by dimensional symptom expression, patients with schizophrenia show an additional dysregulation of striatal activation. Trans-diagnostic approaches are promising in order to disentangle dimensional and categorical neural mechanisms in the psychosis continuum.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  negative symptoms; neuroimaging; positive symptoms; psychosis continuum; reward processing; schizophrenia

Mesh:

Year:  2018        PMID: 27798223      PMCID: PMC5767950          DOI: 10.1093/schbul/sbw142

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  69 in total

Review 1.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

2.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

3.  Self-reflection and the psychosis-prone brain: an fMRI study.

Authors:  Gemma Modinos; Remco Renken; Johan Ormel; André Aleman
Journal:  Neuropsychology       Date:  2011-05       Impact factor: 3.295

4.  Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.

Authors:  M E Kelley; D P van Kammen; D N Allen
Journal:  Am J Psychiatry       Date:  1999-03       Impact factor: 18.112

5.  Assessing sub-clinical psychosis phenotypes in the general population--a multidimensional approach.

Authors:  Wulf Rössler; Vladeta Ajdacic-Gross; Mario Müller; Stephanie Rodgers; Helene Haker; Michael P Hengartner
Journal:  Schizophr Res       Date:  2014-12-15       Impact factor: 4.939

6.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

7.  Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort.

Authors:  Matthias N Hartmann; Oliver M Hager; Anna V Reimann; Justin R Chumbley; Matthias Kirschner; Erich Seifritz; Philippe N Tobler; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2014-07-22       Impact factor: 9.306

Review 8.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

9.  Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Authors:  Henrik Walter; Hannes Kammerer; Karel Frasch; Manfred Spitzer; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2009-06-12       Impact factor: 4.530

10.  Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis.

Authors:  Diana Wotruba; Karsten Heekeren; Lars Michels; Roman Buechler; Joe J Simon; Anastasia Theodoridou; Spyros Kollias; Wulf Rössler; Stefan Kaiser
Journal:  Front Behav Neurosci       Date:  2014-11-18       Impact factor: 3.558

View more
  13 in total

1.  Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia.

Authors:  Karoline Schneider; Lars Michels; Matthias N Hartmann-Riemer; Achim Burrer; Philippe N Tobler; Philipp Stämpfli; Matthias Kirschner; Erich Seifritz; Stefan Kaiser
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

2.  What you want may not be what you like: A test of the aberrant salience hypothesis in schizophrenia risk.

Authors:  Lilian Yanqing Li; Mayan K Castro; Elizabeth A Martin
Journal:  Cogn Affect Behav Neurosci       Date:  2020-08       Impact factor: 3.282

3.  Association between functional and structural connectivity of the corticostriatal network in people with schizophrenia and unaffected first-degree relatives.

Authors:  Peng Li; Ri-Xing Jing; Rong-Jiang Zhao; Le Shi; Hong-Qiang Sun; Zengbo Ding; Xiao Lin; Lin Lu; Yong Fan
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

4.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 5.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

6.  Identification of voxel-based texture abnormalities as new biomarkers for schizophrenia and major depressive patients using layer-wise relevance propagation on deep learning decisions.

Authors:  A I Korda; A Ruef; S Neufang; C Davatzikos; S Borgwardt; E M Meisenzahl; N Koutsouleris
Journal:  Psychiatry Res Neuroimaging       Date:  2021-05-16       Impact factor: 2.493

7.  Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individuals.

Authors:  Marta Stepien; Andrei Manoliu; Roman Kubli; Karoline Schneider; Philippe N Tobler; Erich Seifritz; Marcus Herdener; Stefan Kaiser; Matthias Kirschner
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

8.  Reward Processing in Children With Psychotic-Like Experiences.

Authors:  Jasmine Harju-Seppänen; Haritz Irizar; Elvira Bramon; Sarah-Jayne Blakemore; Liam Mason; Vaughan Bell
Journal:  Schizophr Bull Open       Date:  2021-12-04

9.  Schizotypal traits across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: pathomechanistic insights.

Authors:  Nga Yan Tse; Sicong Tu; Yu Chen; Jashelle Caga; Carol Dobson-Stone; John B Kwok; Glenda M Halliday; Rebekah M Ahmed; John R Hodges; Olivier Piguet; Matthew C Kiernan; Emma M Devenney
Journal:  J Neurol       Date:  2022-03-13       Impact factor: 6.682

10.  The neural mechanisms of social reward in early psychosis.

Authors:  Anne-Kathrin J Fett; Elias Mouchlianitis; Paula M Gromann; Lucy Vanes; Sukhi S Shergill; Lydia Krabbendam
Journal:  Soc Cogn Affect Neurosci       Date:  2019-08-31       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.